<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; expectations</title>
	<atom:link href="http://www.tapanray.in/tag/expectations/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Why And How To Be In-Sync With Gen Z As Pharma Paradigm Shifts?</title>
		<link>http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts</link>
		<comments>http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/#comments</comments>
		<pubDate>Mon, 21 Feb 2022 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[characteristics]]></category>
		<category><![CDATA[conscious]]></category>
		<category><![CDATA[consumers]]></category>
		<category><![CDATA[core]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[financial]]></category>
		<category><![CDATA[Gen Z]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Metamorphosis]]></category>
		<category><![CDATA[Millenials]]></category>
		<category><![CDATA[minded]]></category>
		<category><![CDATA[natives]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[perspective]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[Survey]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[transformation]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10656</guid>
		<description><![CDATA[As science and technology, across the world, are progressing at a scorching pace &#8211; Covid-19 pandemic notwithstanding, today’s generations are growing up tech savvy &#8211; more than ever before. The trend will keep going north faster and with a steeper &#8230; <a href="http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Enhance Customer Experience By Enhancing Employee Experience</title>
		<link>http://www.tapanray.in/enhance-customer-experience-by-enhancing-employee-experience/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=enhance-customer-experience-by-enhancing-employee-experience</link>
		<comments>http://www.tapanray.in/enhance-customer-experience-by-enhancing-employee-experience/#comments</comments>
		<pubDate>Mon, 20 Dec 2021 00:00:59 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[center]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[employee]]></category>
		<category><![CDATA[engagement]]></category>
		<category><![CDATA[Enhance]]></category>
		<category><![CDATA[enhancing]]></category>
		<category><![CDATA[excellence]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[normal]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[performance]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[stage]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10628</guid>
		<description><![CDATA[Pharma is slowly but surely realizing that enhancing their customer experience can help reap a rich harvest by maximizing the business Return on Investments (ROI), significantly. However, the key architects behind creating a roadmap for the same are employees of &#8230; <a href="http://www.tapanray.in/enhance-customer-experience-by-enhancing-employee-experience/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/enhance-customer-experience-by-enhancing-employee-experience/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Pharma Need To Connect Better With Patient Organizations Now?</title>
		<link>http://www.tapanray.in/pharma-need-to-connect-with-patient-organizations-more-than-ever-before/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-need-to-connect-with-patient-organizations-more-than-ever-before</link>
		<comments>http://www.tapanray.in/pharma-need-to-connect-with-patient-organizations-more-than-ever-before/#comments</comments>
		<pubDate>Mon, 09 Aug 2021 00:00:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[commercially]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Connect]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[deliver]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[end-to-nd]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[group]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[low]]></category>
		<category><![CDATA[maximize]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[normal]]></category>
		<category><![CDATA[Organizations]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[Pos]]></category>
		<category><![CDATA[Programms]]></category>
		<category><![CDATA[PSG]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[return]]></category>
		<category><![CDATA[services]]></category>
		<category><![CDATA[Suppor]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[usage]]></category>
		<category><![CDATA[useful]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10564</guid>
		<description><![CDATA[A good number of patients (63%), especially those with chronic ailments would look for Patient Support Services, revealed a survey by Human Healthcare Systems, released on February 25, 2020. Alongside, drug companies are also, reportedly, investing billions of dollars in every year, for several types of &#8230; <a href="http://www.tapanray.in/pharma-need-to-connect-with-patient-organizations-more-than-ever-before/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-need-to-connect-with-patient-organizations-more-than-ever-before/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To Allay Customers’ New Apprehensions Pharma Needs A New Conversation</title>
		<link>http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation</link>
		<comments>http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/#comments</comments>
		<pubDate>Mon, 17 May 2021 00:00:10 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[allay]]></category>
		<category><![CDATA[apprehensions]]></category>
		<category><![CDATA[conversation]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[drus]]></category>
		<category><![CDATA[endpoint]]></category>
		<category><![CDATA[engagement]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[Jimenez]]></category>
		<category><![CDATA[model]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[Waiver]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10505</guid>
		<description><![CDATA[Since the beginning of 2020, witnessing the rapid spread of Covid pandemic with very high global fatality rate &#8211; virtually the entire global populations &#8211; directly or indirectly, have been looking up to the health care industry for help. This, &#8230; <a href="http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>With Changing Customer Behavior Pharma To Leverage AI For Better Engagement</title>
		<link>http://www.tapanray.in/with-changing-customer-behavior-pharma-to-leverage-ai-for-better-engagement/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=with-changing-customer-behavior-pharma-to-leverage-ai-for-better-engagement</link>
		<comments>http://www.tapanray.in/with-changing-customer-behavior-pharma-to-leverage-ai-for-better-engagement/#comments</comments>
		<pubDate>Mon, 05 Apr 2021 00:00:56 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Artificial]]></category>
		<category><![CDATA[behavior]]></category>
		<category><![CDATA[centricity]]></category>
		<category><![CDATA[changing]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[deep]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[direct]]></category>
		<category><![CDATA[drops]]></category>
		<category><![CDATA[dynamics]]></category>
		<category><![CDATA[e-marketing]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[feedback]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[learning]]></category>
		<category><![CDATA[Leverage]]></category>
		<category><![CDATA[machine]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[nasal]]></category>
		<category><![CDATA[online]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[Voice]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10462</guid>
		<description><![CDATA[More than 55 million doses of Coronavirus vaccines were administered in India, reportedly, at the beginning of the last week of March 2021, in what is the world&#8217;s biggest inoculation drive. Notably, amid this mega initiative, the news media simultaneously reported that ‘India is facing a &#8230; <a href="http://www.tapanray.in/with-changing-customer-behavior-pharma-to-leverage-ai-for-better-engagement/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/with-changing-customer-behavior-pharma-to-leverage-ai-for-better-engagement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Pays More: Creating ‘Innovative ‘Customer Experience’ Or ‘Innovative Drugs’?</title>
		<link>http://www.tapanray.in/what-pays-more-creating-innovative-customer-experience-or-innovative-drugs/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=what-pays-more-creating-innovative-customer-experience-or-innovative-drugs</link>
		<comments>http://www.tapanray.in/what-pays-more-creating-innovative-customer-experience-or-innovative-drugs/#comments</comments>
		<pubDate>Mon, 13 Jan 2020 00:00:34 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[branded]]></category>
		<category><![CDATA[brands]]></category>
		<category><![CDATA[business corporate]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[Consumerism]]></category>
		<category><![CDATA[Creating]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[dimension]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[end-to-end]]></category>
		<category><![CDATA[equation]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[Failure]]></category>
		<category><![CDATA[financial]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[innovative]]></category>
		<category><![CDATA[life-cycle]]></category>
		<category><![CDATA[loyal]]></category>
		<category><![CDATA[loyalty]]></category>
		<category><![CDATA[marketers]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[pays]]></category>
		<category><![CDATA[performance]]></category>
		<category><![CDATA[pressure]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[prodrugs]]></category>
		<category><![CDATA[Promotion]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[traditional]]></category>
		<category><![CDATA[unique]]></category>
		<category><![CDATA[word-of-mouth]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9851</guid>
		<description><![CDATA[More innovative a drug is, the better is its business success rate. This was the general perception of around 92 percent pharma professionals in the past three years. Whereas the fact is: ‘Having the best product doesn’t guarantee sales anymore’. &#8230; <a href="http://www.tapanray.in/what-pays-more-creating-innovative-customer-experience-or-innovative-drugs/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/what-pays-more-creating-innovative-customer-experience-or-innovative-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Pharma Communication In Sync With Doctors’ Expectations?</title>
		<link>http://www.tapanray.in/is-pharma-communication-in-sync-with-doctors-expectations/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-pharma-communication-in-sync-with-doctors-expectations</link>
		<comments>http://www.tapanray.in/is-pharma-communication-in-sync-with-doctors-expectations/#comments</comments>
		<pubDate>Mon, 13 May 2019 00:00:33 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[allocation]]></category>
		<category><![CDATA[bridging]]></category>
		<category><![CDATA[channels]]></category>
		<category><![CDATA[communication]]></category>
		<category><![CDATA[company]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[disconnect]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[gaps]]></category>
		<category><![CDATA[in-sync]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Information]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[monitoring]]></category>
		<category><![CDATA[non-personal]]></category>
		<category><![CDATA[outreach]]></category>
		<category><![CDATA[Personal]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Resource]]></category>
		<category><![CDATA[Survey]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[worldwide]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9527</guid>
		<description><![CDATA[Not many pharma companies, especially in India, undertake any ongoing data-based analysis to gain insight on expectations and change in behavioral pattern of their customers, particularly doctors and patients. Many developments are taken as obvious, such as, when busy practitioners &#8230; <a href="http://www.tapanray.in/is-pharma-communication-in-sync-with-doctors-expectations/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/is-pharma-communication-in-sync-with-doctors-expectations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Managing Pharma Investors’ Expectations When The Chips Are Down</title>
		<link>http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=managing-pharma-investors-expectations-when-the-chips-are-down</link>
		<comments>http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/#comments</comments>
		<pubDate>Sun, 18 Jun 2017 23:34:19 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[accountability.]]></category>
		<category><![CDATA[activist]]></category>
		<category><![CDATA[bans]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Chips]]></category>
		<category><![CDATA[Compliance]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[down]]></category>
		<category><![CDATA[Ethics]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[export]]></category>
		<category><![CDATA[import]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Investors]]></category>
		<category><![CDATA[Managing]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Points]]></category>
		<category><![CDATA[practices]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[shareholders]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Trump]]></category>
		<category><![CDATA[USFDA]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8282</guid>
		<description><![CDATA[Triggered by several critical factors, over a relatively short period of time, a downward spiral is visible with most Indian Pharma stocks, with a significant erosion in market capitalization of many large players in the country. A set of important &#8230; <a href="http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Millennial Generation Doctors And Patients: Changing Mindset, Aspirations, And Expectations</title>
		<link>http://www.tapanray.in/millennial-generation-doctors-and-patients-changing-mindset-aspirations-and-expectations/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=millennial-generation-doctors-and-patients-changing-mindset-aspirations-and-expectations</link>
		<comments>http://www.tapanray.in/millennial-generation-doctors-and-patients-changing-mindset-aspirations-and-expectations/#comments</comments>
		<pubDate>Sun, 06 Nov 2016 23:57:32 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[adherence]]></category>
		<category><![CDATA[Allergan]]></category>
		<category><![CDATA[andrew]]></category>
		<category><![CDATA[Aspirations]]></category>
		<category><![CDATA[baby]]></category>
		<category><![CDATA[boomers]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[Brent]]></category>
		<category><![CDATA[changing]]></category>
		<category><![CDATA[Citizens']]></category>
		<category><![CDATA[communication]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[demographic]]></category>
		<category><![CDATA[demography]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[dividend]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[Generation]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[inventive]]></category>
		<category><![CDATA[leadership]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Millennial]]></category>
		<category><![CDATA[mindset]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reps]]></category>
		<category><![CDATA[reputation]]></category>
		<category><![CDATA[Saunders]]></category>
		<category><![CDATA[savvy]]></category>
		<category><![CDATA[senior]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[top]]></category>
		<category><![CDATA[trust]]></category>
		<category><![CDATA[witty]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7948</guid>
		<description><![CDATA[The term ‘Millennial Generation’ normally refers to the generation, born from 1980 onward, brought up using digital technology and mass media. According to ‘Millennial Mindset’ – a website dedicated to helping businesses understand millennial employees and new ways of working, &#8230; <a href="http://www.tapanray.in/millennial-generation-doctors-and-patients-changing-mindset-aspirations-and-expectations/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/millennial-generation-doctors-and-patients-changing-mindset-aspirations-and-expectations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare In India (2016-17): Whither Goest Thou?</title>
		<link>http://www.tapanray.in/healthcare-in-india-2016-17-whither-goest-thou/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=healthcare-in-india-2016-17-whither-goest-thou</link>
		<comments>http://www.tapanray.in/healthcare-in-india-2016-17-whither-goest-thou/#comments</comments>
		<pubDate>Mon, 29 Feb 2016 00:00:47 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2015-16]]></category>
		<category><![CDATA[2016-17]]></category>
		<category><![CDATA[Budget]]></category>
		<category><![CDATA[cess]]></category>
		<category><![CDATA[economic]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[Goest]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[My]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Report]]></category>
		<category><![CDATA[Survey]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Thou]]></category>
		<category><![CDATA[Union]]></category>
		<category><![CDATA[Whither]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7497</guid>
		<description><![CDATA[The Union Budget 2016-17 will be proposed today by the Finance Minister before the Indian Parliament. As many critical questions are currently being raised about the real health of the Indian economy, across the globe, the Union Finance Minister shoulders &#8230; <a href="http://www.tapanray.in/healthcare-in-india-2016-17-whither-goest-thou/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/healthcare-in-india-2016-17-whither-goest-thou/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
